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analysis in patients with heart rhythm disorders
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Abstract
Background/Aim. A possible cause of malignant heart
rhythm disorders is the syndrome of sleep apnea (periodic
cessation of breathing during sleep longer than 10 seconds).
Recent 24h ECG software systems have the option of de-
termination ECG apnea index (AI) based on the change in
voltage of QRS complexes. The aim of the study was to
determine the significance of AI evaluation in routine 24-
hour Holter ECG on a group of 12 patients. Methods. We
presented a total of 12 consecutive patients with previously
documented arrhythmias and the history of breathing disor-
ders during night. They were analyzed by 24 h ECG (Me-
dilog AR 12 plus Darwin), that is able to determine AI. Re-
sults. We presented a case series of 12 patients, 8 men and
4 women, mean age 58.75 years and the average AI 5.78. In
the whole group there was a trend of increasing prevalence
of complex rhythm disorders with increasing of AI and in-
creased frequency of arrhythmias in the night phase vs day
phase. Conclusion. Determination of AI using routine long
term (24 h) ECG analysis is important because sleep apnea
can be successfully treated as an etiological or contributing
factor of arrhythmias.
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Apstrakt
Uvod/Cilj. Jedan od moguýih uzroka malignih poremeýaja
ritma srca na koji se ne obraýa dovoljno pažnja je sindrom
poremeýaja disanja u toku spavanja poznat kao sleep apnea (pe-
riodiÿni prekid disanja u toku spavanja duži od 10 sekundi).
Noviji softverski sistemi holter EKG-a imaju moguýnost od-
reĀivanja apneja indeksa (AI) na osnovu promene voltaže
QRS kompleksa. Cilj ovog rada bio je utvrĀivanje znaÿaja od-
reĀivanja AI u rutinskoj  analizi holter EKG-a na uzorku od
12 bolesnika. Metode. Prikazana je grupa od 12 uzastopnih
bolesnika sa prethodno dokazanim aritmijama i istorijom po-
remeýaja disanja tokom noýi. Svi su bili podvrgnuti 24 h hol-
ter EKG analizi (Medilog 12 plus Darwin) koja omoguýava
odreĀivanje AI. Rezultati. Prikazali smo seriju od 12 boles-
nika, 8 muškaraca i 4 žene, proseÿne starosti 58,75 godina i
proseÿnog AI od 5,78. U celokupnoj grupi postojao je trend
poveýanja uÿestalosti kompleksnih poremeýaja ritma sa pove-
ýanjem AI i uÿestalosti aritmije u noýnoj fazi u odnosu na
dnevnu fazu. Zakljuÿak. S obzirom na moguýnost leÿenja
apneje u snu kao etiološkog ili doprinoseýeg faktora u nastan-
ku i pogoršanju aritmija, odreĀivanje AI rutinskom primenom
holter EKG-a od velikog je znaÿaja.
Kljuÿne reÿi:
apneja, spavanje poremeýaji, sindromi; aritmija;
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Introduction
A possible cause of malignant arrhythmias that is often
forgotten is a syndrome of breathing disorders during sleep,
known as sleep apnea 
1. Besides, arrhythmias sleep apnea is
a potential cause of many adverse cardiovascular events such
as myocardial ischemia, and hypertension. Sleep apnea is de-
fined as periodic interruption of breathing during sleep
longer than 10 seconds. Hypopnea in adults is characterized
by drop of nasal pressure at least 30% (compared to the basal
state), of at least, 10 seconds associated with oxygen desatu-
ration of  4%. Apnea index (AI) is the number of these epi-
sodes (apnea and hypopnea) per hour of sleep.
There are two main types of sleep apnea: obstructive
sleep apnea (OSA), which occurs when the throat muscles
collapse, due to different functional disorders of nose, use of
sedatives, short neck, obesity; and central sleep apnea (CSA)
the brain does not send proper signals to the muscles that
control breathing.
Polysomnography is the gold standard in the diagnosis
of sleep apnea in specialized laboratories. It is expensive and
requires training staff and in our country is rarely used, only
in scientific purposes.
The percentage of rhythm disorders caused by apnea
is significant 
2. Guilleminault at al. 
2 in the long term ECG
analysis found that 3% of the 400 patients with OSA had
atrial fibrillation 
3, 4, which is significantly higher compar-
ing the prevalence of atrial fibrillation in the general popu-
lation, although there is evidence that in the population of
patients with atrial fibrillation the incidence of OSA is
higher than in the general population 
5. In addition, a high
incidence of recurrent atrial fibrillation was documented in
the first year after cardioversion in patients with sleep ap-
nea who were not treated with Continuous Positive Airway
Pressure (CPAP) 
6.
The newer software systems of long term ECG (12-
channel ECG recording) have the option of determining the
apnea index based on changes in QRS voltage that changes
due to minimal changes in the axis of the heart that occur
during respiration/breathing interruptions, known as ECG
derived respiration signal (EDRF) (Figures 1 and 2).
During episodes of interrupted breathing, heart rate
compensatory increases and that period of heart rate os-
cillation correlates with the period of time from one epi-
sode to the next episode of apnea of EDRF signal (Fig-
ure 3).
Small changes of the vector result in very small changes
in ECG amplitudes of a few μV which is possible to be re-
corded by the high resolute 24h ECG devices.
That is why a simple and inexpensive examination by
24 h ECG (comparing to the specialized respiratory laborato-
ries) may be used as screening test for patients with breath-
ing disorders during sleeping. This may improve etiologic
treatment of arrhythmias, without unnecessary or improper
use of antiarrhythmic drugs even implantation of pace-maker
devices.
Heart Rate
EDR
30sec 30sec 30sec
30sec
Fig. 1 – Episodes of apnea occur periodically leading to significant fluctuations of the heart rate. The length of these
oscillations correlates with the period of time from one to the next apnea on the presented electrocardiogram (ECG) derived
respiration (EDR) signal.
Expiration Inspiration Expiration
Fig. 2 – The heart is slightly raised and moves during inspiration and expiration flow related to a fixed position of the
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Methods
We presented a total of 12 consecutive patients with
previously documented arrhythmias and history of breathing
disorders during night. They were analyzed by 24 h ECG,
(Medilog AR 12 plus Darwin), that is able to determine AI.
The study group consisted of 8 men and 4 women aged from
42 to 65 years, average 58,75 years. The average AI was
5,78 (min AI = 0 , max AI = 18).
There was an increase in the incidence of complex
rhythm disorders with an increase of AI (except for the pa-
tient ID 12, who had 78 episodes of pauses), and increase in
the incidence of all kinds of arrhythmia during the night
comparing with the the day phase. Concerning the previous
data in the literature 
6 that symptomatic patients with AI >5
are candidates for treatment with CPAP, and patients with AI
> 20 have the absolute indication for administration of
CPAP, we divided our patients into two groups, the group I =
AI < 5 and the group II = AI > 5. In the group II (with
breathing disorders during sleeping) all the patients (100%)
were men, with hypertension and smoking habit, data that
“they stop breath during the sleep”, and 60% were obese ac-
cording to body mass index (BMI). Also, 80% in this group
met criteria for metabolic syndrome (Table 1).
Concerning complex rhythm disorders in the group I we
found 42% of the patients with this arrhythmia (Lawn III, IV
or V class) vs 80% patients in the group II. All the patients in
the group II had more than 50% episodes of arrhythmia dur-
ing the night phase. In the patients with AI > 15 we detected
pauses of more than 2 s and their number was in correlation
with AI (Table 2).
We selected and presented the patient ID 7 from the
group I, with AI = 2.29, and arrhythmias by the Lawn classi-
fication IV, 2,700 premature ventricular complex (PVC). The
 Fig. 3 – Heart rate compensatory increases during the episodes of interrupted breathing.
Table 1   
Apnea index (AI), rhythm disorders and heart rate variability in the study population
ID AI Pause Tachycardia VES Night arrh % CI SDNNi SDANNi Qtcdisp
1 0 0 0 L3 0 1.21 87.0 172.1 511
2 0.29 0 0 0 0 0.95 32.2 90.2 303
3 0.29 4 1 L1 0 1.30 62.7 136.7 284
4 0.71 3 3 L4 0 1.36 40.5 124.2 344
5 1,57 0 0 0 0 0.93 27.3 85.7 434
6 2.0 7 6 0 0 1.11 119.6 211.6 601
7 2.29 0 0 L4 80 1.35 67.5 137.2 458
8 5.29 0 0 L3 62 0.88 42.6 84.4 383
9 8.0 0 0 L4 52 1.23 106.9 75.2 717
10 15 5 0 L5 68 1.19 60.0 84.0 413
11 16 27 0 L4 73 1.09 56.1 98.6 416
12 18 78 2 0 89.7 1.24 88.6 47.1 787
ID – patient’s identification number; CI – circardial index; VES – ventricular extrasystoles; Qtcdisp – Qtc disperzion; SDNNi – average value
of all standard deviation PR interval; SDANNi – standard deviation of all the average values.
Table 2
Main characteristics of the study group
ID Gender Age (year) BMI Msy Smoking HTA SAH DN
1F 6 4 1 00 0 0 0
2F 5 1 0 10 1 0 0
3M 4 2 0 0 0 000
4F 5 3 1 11 1 0 0
5F 5 5 0 11 1 1 1
6M 6 9 1 0 1 111
7M 4 2 0 1 0 110
8M 5 4 1 0 1 110
9M 6 6 0 1 1 111
10 M 73 0 1 1 1 1 1
11 M 58 1 1 1 1 1 1
12 M 78 1 1 1 1 1 1
ID – patient’s identification number; BMI – body mass index, 1 > 0.25 kg/m
2;
Msy – metabolic syndrome; SAH – history of cessation of breathing at night;
DN – information on the deviation of the nose; F – female; M –male.Strana 1052 VOJNOSANITETSKI PREGLED Volumen 71, Broj 11
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patient had 80% of complex arrhythmia episodes recorded in
the night phase in the periods of breathing cessation (Table
2). The patient had the history of viral myocarditis a year ago
when 24 h ECG was also performed using standard 24 h
ECG (it was recorded PVC 5100, Lawn 4, but without the
possibility of determining the AI). All the signs of myocar-
ditis on this control check up were negative (clinical, labo-
ratory and echocardiography findings), and VES might be
induced not only by viral myocarditis. This patient also gave
information about deviation nose which may be a predis-
posing factor for the development OSA. He was overweight,
not a smoker, blood pressure values were slightly higher in
the morning hours to a maximum of 150/90 mmHg without
treatment. He was referred to additional throat examination
and operative correction.
We also presented the patient ID 12 from the group II,
with 78 episodes of  OSA type block longer than 2.0 seconds
and Mobitz type I and II [70 (89.7%) episodes in the night
phase] (Figure 4). This patient was obese, excessive smoker
with a large-scale neck, unregulated hypertension, morning
headaches, disorientation and fatigue. Echocardiography
showed slightly impaired global systolic function, diastolic
dysfunction grade II. Hypertension was treated using angio-
tensin-converting enzyme (ACE) inhibitors and calcium an-
tagonists.
The patients with AI > 5 were advised to perform poly-
somnography, but we have not been able to perform it.
Discussion
Sleep apnea is a disorder that in many ways diminishes
the quality of life of patients and increases cardiovascular
morbidity and mortality 
7. The literature rather analyzes the
phenomena of cardiovascular events in patients with breath-
ing disorders. The obstructive sleep apnea is associated with
several heart diseases, most notably hypertension, ischemic
heart disease, heart failure, stroke, rhythm disorders and
pulmonary hypertension
 2. Our study included patients with
both history of breathing disorders during night and rhythm
disorders. We tried to determine if abnormal breathing dur-
ing sleep was a contributing factor for arrhythmias.
Ventricular arrhythmias show circadian rhythm with the
highest incidence of occurrence of midnight (0 h) to 6 h in
the morning. This could be one of the reasons for the in-
creased incidence of ventricular arrhythmias in patients with
OSA, although increased oxygen desaturation during OSA is
certainly a contributing factor 
8.
The predisposing factors for sleep apnea are: obesity,
hypertension, broad neck (short, thick neck), narrow airways,
smoking 
9. People with this disorder often snore at night and
have elevated blood pressure during the night and early
morning, morning headaches, depression, memory problems.
Data from the literature suggest that these noncardiac mani-
festations can lead to sudden cardiac death, because patients
with sleep apnea are sleepy during the day phase, have loss
of concentration and, therefore, have an increased incidence
of traffic accidents 
10. All the presented patients in this study
had all of the above predisposing factors (smoking, obesity,
metabolic syndrome and hypertension). The consequences in
terms of daily loss of concentration and sleepiness had only
patient ID 11 and ID 12 in which the AI > 15, which is con-
sistent with literature data.
Sleep apnea is associated with prolonged episodes of
hypoxemia which triggers the reflex similar during drown-
ing. This reflex has a duty to preserve oxygen to the vital or-
Fig. 4 – Correlation of the episodes of sleep apnea and pauses noted on the electrocardiogram.Volumen 71, Broj 11 VOJNOSANITETSKI PREGLED Strana 1053
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gans, the brain and the heart, reducing blood flow to the pe-
riphery which consists of sympathetic vasoconstriction (re-
flected in the periphery) and the vagal response that affects
the heart. Effects on the heart are various conduction disor-
ders that occur in patients with OSA 
8, 10 such as sinoatrial
block, sinus arrest, AV conduction disorders, even asystole.
It has been shown that these patients have no structural and
anatomical changes in the conduction system and rhythm
disorders were the result of increased parasympathetic tone
due to hypoxemia. These conduction abnormalities are re-
versible and disappear after the use of CPAP 
8. These brady-
arrhythmias, SA and AV conduction abnormalities and ven-
tricular premature beats and complex type of atrial fibrilla-
tion may predispose and lead to sudden cardiac death. This
risk is increased in patients with associated risk factors for
cardiovascular events, so detection of breathing disorders in
these patients could be the obligatory diagnostic procedure,
if technically possible. Since the presented group was a ran-
dom sample of patients who came to perform 24 h ECG due
to arrhythmias, complex ventricular arrhythmias were more
common than pauses  (higher incidence in the literature), but
the patients ID 11 and ID 12 with AI > 15 had recorded a
significant number of pauses which occurred during periods
of apnea consistent with previous research 
11–13.
In the previous studies the heart rate variability (HRV)
showed that HRV was expressed in the severe cases of OSA.
On the contrary, in patients with milder degrees of OSA, in
patients who take amiodarone, sotalol, propafenon, nebivo-
lol, bisoprolol and very elderly people with “rigid heart
rhythm”, HRV was not pronounced 
14, 15. In our study, there
were no statistically significant difference in parameters of
HRV, also.
This pilot study showed the significance of determining
AI in patients with rhythm disorders in order to establish
cause and determine further diagnosis and treatment. In fact
people with AI > 5 are referred for further diagnostic of sleep
apnea. Also, we advise them to correct habits of living, re-
duce and/or eliminate use of medications that predispose
manifestation of respiratory distress (sedatives), and to visit
the throat specialist to correct existing anomalies. If sleep
apnea is confirmed in the specialized laboratory, than the ap-
plication of CPAP will be the best form of treatment for ar-
rhythmia and apnea.
Standard cardiorespiratory monitoring is complex in-
cluding: nasal airflow, measurement of saturation (pulse
oxygen meter), determination of HRV and determination of
“respiratory movements”. Laboratories for cardiorespiratory
monitoring and polysomnography in our country are not
available in routine clinical practice due to methods com-
plexity, the need for special equipment and high costs of
treatment.
Unfortunately, there are no studies on a large number of
patients that compared the results of classical polysomnogra-
phy 24 h ECG with respiratory monitoring. But the available
literature data suggest that the sensitivity and specificity of
this method in determining of sleep apnea are satisfac-
tory 
16, 17.
Conclusion
The conclusion of this pilot study is that respiratory
analysis of apnea index by appropriate 24 h ECG is precious
in patients with arrhythmias, as well as in the group of pa-
tients with suspected breathing disorders during sleep, as
primary screening of patients with sleep apnea and dynamic
screening of patients who are treated with CPAP. Further in-
vestigations by the cardiologists in our country in this field
are necessary.
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